A detailed history of Nbc Securities, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Nbc Securities, Inc. holds 200 shares of GMAB stock, worth $4,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$4,118
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$25.13 - $30.27 $5,528 - $6,659
-220 Reduced 52.38%
200 $5,000
Q1 2024

Apr 05, 2024

SELL
$26.43 - $32.77 $13,082 - $16,221
-495 Reduced 54.1%
420 $12,000
Q4 2023

Feb 07, 2024

SELL
$27.94 - $35.44 $3,967 - $5,032
-142 Reduced 13.43%
915 $29,000
Q3 2023

Nov 03, 2023

BUY
$35.27 - $42.24 $37,280 - $44,647
1,057 New
1,057 $37,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.